Stay updated on COTEZO IMblaze370 Clinical Trial
Sign up to get notified when there's something new on the COTEZO IMblaze370 Clinical Trial page.

Latest updates to the COTEZO IMblaze370 Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check19 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, particularly in South Korea, Russia, and Italy, as well as the inclusion of relevant medical topics related to colorectal cancer. Notably, the term 'regorafenib' has been removed, which may impact the context of cancer treatment discussions.SummaryDifference15%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to COTEZO IMblaze370 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COTEZO IMblaze370 Clinical Trial page.